Test Volume Drives Up NeoGenomics' Q4 Revenues 47 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cancer genomics testing service firm NeoGenomics today said that fourth-quarter revenues rose 47 percent year over year.

The Fort Myers, Fla.-based company posted $12.9 million in revenues for the three months ended Dec. 31, 2011, up from $8.8 million a year ago. The firm said that while test volume increased 57 percent year over year, the average revenue per test decreased 6 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.